{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T05:24:24Z","timestamp":1782883464885,"version":"3.54.5"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAR"],"published-print":{"date-parts":[[2026,6,29]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Lecanemab is a monoclonal antibody targeting amyloid-\u03b2 (A\u03b2) and is currently\nused in clinical practice for the treatment of early Alzheimer's disease (AD). However, noninvasive\nbiomarkers reflecting its early efficacy are still unclear. This exploratory case report aims\nto investigate the combination of eye movement and gait analysis to quantitatively monitor shortterm\nfunctional changes during lecanemab treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Presentation:<\/jats:title>\n                    <jats:p>Two male patients, both diagnosed with mild Alzheimer's disease through amyloid-\nPET and both with the APOE \u03b53\/\u03b53 genotype, received intravenous lecanemab (10 mg\/kg, every\ntwo weeks) for three months. Cognitive assessments (Montreal Cognitive Assessment, Mini-\nMental State Examination, Clinical Dementia Rating), eye movement tests (smooth pursuit, overlapping\nsaccades, anti-saccades), and gait analysis under single-task and dual-task conditions were\nconducted at baseline and follow-up. Patient 1 (79 years old) showed stable cognitive function, significant\nimprovement in multiple eye movement parameters, and partial improvement in gait under\nsingle-task conditions. Patient 2 (60 years old) did not follow up on cognitive function tests as\nscheduled and showed inconsistent changes in eye movement parameters, but improved selected gait\nmeasures under dual-task conditions, particularly a shorter turning time. Neither patient experienced\nAmyloid-Related Imaging Abnormalities or infusion-related adverse events during the infusion process.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This exploratory case report suggests that eye movement and gait analysis may be sensitive\nto short-term functional changes following lecanemab treatment, which were not consistently\ncaptured by traditional cognitive scales. These findings are hypothesis-generating and warrant further\ninvestigation in larger studies. Multimodal functional assessment may hold promise as a tool for\nmonitoring early treatment effects in Alzheimer's disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115672050471024260520113701","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:14:34Z","timestamp":1782879274000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantifying Short-Term Functional Changes After Lecanemab Treatment\nin Early Alzheimer's Disease: An Exploratory 3-Month Follow-Up Case\nReport Using Eye Movement and Gait Analysis"],"prefix":"10.2174","volume":"23","author":[{"given":"Yao","family":"Li","sequence":"first","affiliation":[{"name":"Department of Neurology and Neuroscience Centre, The First Hospital of Jilin University, Changchun, 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyue","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neuroscience Centre, The First Hospital of Jilin University, Changchun, 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyv","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neuroscience Centre, The First Hospital of Jilin University, Changchun, 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixun","family":"wang","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neuroscience Centre, The First Hospital of Jilin University, Changchun, 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neuroscience Centre, The First Hospital of Jilin University, Changchun, 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghao","family":"Si","sequence":"additional","affiliation":[{"name":"Medical Affairs Department, Eisai China Inc., Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Alzheimer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115672050471024260520113701","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/255570\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115672050471024260520113701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:14:36Z","timestamp":1782879276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/255570\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115672050471024260520113701","relation":{},"ISSN":["1567-2050"],"issn-type":[{"value":"1567-2050","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2026-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}